Existence of autocrine loop between interleukin-6 and transforming growth factor-beta1 in activated rat pancreatic stellate cells - PubMed (original) (raw)

. 2006 Sep 1;99(1):221-8.

doi: 10.1002/jcb.20906.

Affiliations

• PMID: 16598747
• DOI: 10.1002/jcb.20906

Existence of autocrine loop between interleukin-6 and transforming growth factor-beta1 in activated rat pancreatic stellate cells

Hiroyoshi Aoki et al. J Cell Biochem. 2006.

Abstract

Interleukin (IL)-6 is a proinflammatory cytokine assumed to participate in pancreatic fibrosis by activating pancreatic stellate cells (PSCs). Autocrine TGF-beta1 is to central in PSC functional regulation. In this study, we examined IL-6 secretion from culture-activated rat PSCs and its regulatory mechanism. Activated PSCs express and secrete IL-6. When anti-TGF-beta1 neutralizing antibody was added in the culture medium, IL-6 secretion from activated PSCs was inhibited, whereas exogenous TGF-beta1 added in the culture medium enhanced IL-6 expression and secretion by PSCs in a dose dependent manner. Infection of PSCs with an adenovirus expressing dominant-negative Smad2/3 attenuated basal and TGF-beta1-stimulated IL-6 expression and secretion of PSCs. We also demonstrated the reciprocal effect of PSCs-secreted IL-6 on autocrine TGF-beta1. Anti-IL-6 neutralizing antibody inhibited TGF-beta1 secretion from PSCs. Preincubation of cells with 10 nM PD98059, an extracellular signal-regulated kinase (ERK)-dependent pathway inhibitor, attenuated IL-6-enhanced TGF-beta1 expression and secretion of PSCs. In addition, IL-6 activated ERK in PSCs. These data indicate the existence of autocrine loop between IL-6 and TGF-beta1 through ERK- and Smad2/3-dependent pathways in activated PSCs.

PubMed Disclaimer

Similar articles

• Autocrine loop between TGF-beta1 and IL-1beta through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells.
  Aoki H, Ohnishi H, Hama K, Ishijima T, Satoh Y, Hanatsuka K, Ohashi A, Wada S, Miyata T, Kita H, Yamamoto H, Osawa H, Sato K, Tamada K, Yasuda H, Mashima H, Sugano K. Aoki H, et al. Am J Physiol Cell Physiol. 2006 Apr;290(4):C1100-8. doi: 10.1152/ajpcell.00465.2005. Epub 2005 Dec 21. Am J Physiol Cell Physiol. 2006. PMID: 16371439
• Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines.
  Aoki H, Ohnishi H, Hama K, Shinozaki S, Kita H, Osawa H, Yamamoto H, Sato K, Tamada K, Sugano K. Aoki H, et al. Am J Physiol Cell Physiol. 2007 Jan;292(1):C259-68. doi: 10.1152/ajpcell.00030.2006. Epub 2006 Jul 12. Am J Physiol Cell Physiol. 2007. PMID: 16837651
• Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
  Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV. Phillips PA, et al. Gut. 2003 Feb;52(2):275-82. doi: 10.1136/gut.52.2.275. Gut. 2003. PMID: 12524413 Free PMC article.
• Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions.
  Ohnishi H, Miyata T, Yasuda H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, Makita N, Iiri T, Ueda N, Mashima H, Sugano K. Ohnishi H, et al. J Biol Chem. 2004 Mar 5;279(10):8873-8. doi: 10.1074/jbc.M309698200. Epub 2003 Dec 18. J Biol Chem. 2004. PMID: 14688282
• Pathogenic mechanisms of pancreatitis.
  Manohar M, Verma AK, Venkateshaiah SU, Sanders NL, Mishra A. Manohar M, et al. World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):10-25. doi: 10.4292/wjgpt.v8.i1.10. World J Gastrointest Pharmacol Ther. 2017. PMID: 28217371 Free PMC article. Review.

Cited by

• Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth.
  Donahue KL, Watkoske HR, Kadiyala P, Du W, Brown K, Scales MK, Elhossiny AM, Espinoza CE, Lasse Opsahl EL, Griffith BD, Wen Y, Sun L, Velez-Delgado A, Renollet NM, Morales J, Nedzesky NM, Baliira RK, Menjivar RE, Medina-Cabrera PI, Rao A, Allen B, Shi J, Frankel TL, Carpenter ES, Bednar F, Zhang Y, Pasca di Magliano M. Donahue KL, et al. Cancer Discov. 2024 Oct 4;14(10):1964-1989. doi: 10.1158/2159-8290.CD-24-0100. Cancer Discov. 2024. PMID: 38958646 Free PMC article.
• Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer.
  Mitsunaga S, Ikeda M, Imaoka H, Sasaki M, Watanabe K, Sato A, Aoki K, Ochiai A, Makikawa M, Nishidate M, Yamaguchi K, Terao K, Sawada N, Fujitomo T, Fujii E, Kato A, Tsunoda H. Mitsunaga S, et al. Cancer Sci. 2023 Oct;114(10):4006-4019. doi: 10.1111/cas.15929. Epub 2023 Aug 21. Cancer Sci. 2023. PMID: 37605479 Free PMC article.
• Nintedanib Alleviates Chronic Pancreatitis by Inhibiting the Activation of Pancreatic Stellate Cells via the JAK/STAT3 and ERK1/2 Pathways.
  Han C, Wang LJ, Dong ZQ, Wang PY, Lv YW, Wang D, Hu LH. Han C, et al. Dig Dis Sci. 2023 Sep;68(9):3644-3659. doi: 10.1007/s10620-023-08052-7. Epub 2023 Aug 1. Dig Dis Sci. 2023. PMID: 37526905
• Suppression of TGFβ-Induced Interleukin-6 Secretion by Sinulariolide from Soft Corals through Attenuation of the p38-NF-kB Pathway in Carcinoma Cells.
  Yang JL, Lin WL, Tai SB, Ciou YS, Chung CL, Chen JJ, Liu PF, Lin MW, Chen CL. Yang JL, et al. Int J Mol Sci. 2023 Jul 19;24(14):11656. doi: 10.3390/ijms241411656. Int J Mol Sci. 2023. PMID: 37511415 Free PMC article.
• Synovial Macrophage and Fibroblast Heterogeneity in Joint Homeostasis and Inflammation.
  Knab K, Chambers D, Krönke G. Knab K, et al. Front Med (Lausanne). 2022 Apr 25;9:862161. doi: 10.3389/fmed.2022.862161. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35547214 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Miscellaneous

  • NCI CPTAC Assay Portal